← Evidence map

ArticleThe New England journal of medicine2014

Phase 3 trials of solanezumab and bapineuzumab for Alzheimer's disease.

Stephen Salloway et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

37 papers cite it

2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
this papertrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 24724181